Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F9 | P00740 | 1/20 | 0.36 |
| ▸ | PLAU | P00749 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.31 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29222395 | 0.84 | KMT2A (0.42) | KMT2AALDH1A1KDM4EGAAHPGD | |
| SCHEMBL29222393 | 0.84 | KMT2A (0.42) | KMT2AALDH1A1KDM4EGAAHPGD | |
| SCHEMBL22804135 | 0.77 | TDP1 (0.38) | KMT2AMEN1MAPTL3MBTL1POLB | |
| SCHEMBL19313103 | 0.70 | — | — | |
| SCHEMBL6426140 | 0.70 | NPC1 (0.31) | KMT2AMEN1HPGD | |
| SCHEMBL27625231 | 0.70 | ALOX15 (0.36) | KMT2AMEN1MAPTSMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29907682 | 0.69 | GAA (0.36) | KMT2AMEN1MAPTALDH1A1KDM4E | |
| SCHEMBL30065084 | 0.69 | MEN1 (0.41) | KMT2AMEN1MAPTL3MBTL1SMN1; SMN2 | |
| SCHEMBL3902859 | 0.68 | ALOX5 (0.45) | MAPTL3MBTL1SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL3436120 | 0.67 | CYP1A2 (0.51) | KMT2AMEN1MAPTALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220354860-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | FOCHON PHARMACEUTICALS, LTD. (CN) | 2022-11-10 | — | — | US | disclosed |
| EP-3983415-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | Fochon Pharmaceuticals, Ltd. (CN) | 2022-04-20 | — | — | EP | disclosed |
| WO-2020253659-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | FOCHON PHARMACEUTICALS, LTD. (CN) | 2020-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220354860-A1 | HETEROCYCLIC DERIVATIVES AND USE THEREOF | NUDT1, UGP2, NUDT21 | F9 4805/4885PLAU 315/4885KMT2A 1693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.